Marvell (MRVL) PT Raised to $195 at UBS
Tweet
Share
E-mailGet Alerts MRVL Hot Sheet
Price: $307.86 -0.88%
Rating Summary:
50 Buy, 11 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 18 | Down: 12 | New: 24
Rating Summary:
50 Buy, 11 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 18 | Down: 12 | New: 24
Join SI Premium – FREE
UBS analyst Timothy Arcuri raised the price target on Marvell (NASDAQ: MRVL) to $195.00 (from $120.00) while maintaining a Buy rating.
You May Also Be Interested In
- Incyte (INCY) PT Raised to $105 at Truist Securities
- Credo Tech (CRDO) PT Raised to $350 at Stifel
- Definium Therapeutics Inc (DFTX) PT Raised to $52 at Leerink
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
